Search filters

List of works by Friedegund Meier

BRAF inhibitors amplify the pro-apoptotic activity of MEK inhibitors by inducing ER stress in NRAS-mutant melanoma

scientific article published on 19 July 2017

Baseline Biomarkers for Outcome of Melanoma Patients Treated with Pembrolizumab

scientific article

Clinical outcome of concomitant vs interrupted BRAF inhibitor therapy during radiotherapy in melanoma patients.

scientific article published on 13 February 2018

Combined immune checkpoint blockade for metastatic uveal melanoma: a retrospective, multi-center study

scientific article published on 13 November 2019

Exploring the Most Visible German Websites on Melanoma Immunotherapy: A Web-Based Analysis

article

Function and regulation of melanoma-stromal fibroblast interactions: when seeds meet soil

scientific article

Inhibition of PI3K-AKT-mTOR signaling sensitizes melanoma cells to cisplatin and temozolomide

scientific article

Integrating Patient Data Into Skin Cancer Classification Using Convolutional Neural Networks: Systematic Review

publication published on 02 July 2021

Ipilimumab in metastatic melanoma patients with pre-existing autoimmune disorders

scientific article published on 27 February 2018

Ligand-independent EPHA2 signaling drives the adoption of a targeted therapy-mediated metastatic melanoma phenotype

scientific article

Melanoma Brain Metastases: Local Therapies, Targeted Therapies, Immune Checkpoint Inhibitors and Their Combinations-Chances and Challenges.

scientific article published on 7 February 2018

Myositis and neuromuscular side-effects induced by immune checkpoint inhibitors

scientific article published on 17 November 2018

PI3K Pathway Inhibition Achieves Potent Antitumor Activity in Melanoma Brain Metastases In Vitro and In Vivo

scientific article published on 15 June 2016

Patterns of care and follow-up care of patients with uveal melanoma in German-speaking countries: a multinational survey of the German Dermatologic Cooperative Oncology Group (DeCOG)

scientific article published on 21 November 2020

Prognostic factors and outcomes in metastatic uveal melanoma treated with programmed cell death-1 or combined PD-1/cytotoxic T-lymphocyte antigen-4 inhibition

scientific article

Prognostic factors and treatment outcomes in 444 patients with mucosal melanoma.

scientific article

Programmed cell death protein-1 (PD-1) inhibitor therapy in patients with advanced melanoma and preexisting autoimmunity or ipilimumab-triggered autoimmunity

scientific article published on 16 February 2017

Targeting hyperactivation of the AKT survival pathway to overcome therapy resistance of melanoma brain metastases

scientific article published on 03 February 2013

The farnesyl transferase inhibitor lonafarnib inhibits mTOR signaling and enforces sorafenib-induced apoptosis in melanoma cells

scientific article published on 14 October 2010

The future of targeted therapy approaches in melanoma.

scientific article published on April 2009

Vemurafenib potently induces endoplasmic reticulum stress-mediated apoptosis in BRAFV600E melanoma cells

scientific article published on 29 January 2013